18m
NDV-01 is a novel, sustained-release, intravesical gemcitabine/docetaxel, ready-for-use product candidate for the treatment of non-muscle ...
Charles Schwab Investment Management Inc. increased its position in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report ...
GENFIT completes a royalty financing of up to €185 million with HCRx after unanimous OCEANE bondholder approval, triggering a €130 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback